Hereditary Cancer Syndrome: Clinical Trials

12 trials for Hereditary Cancer Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 2 active not recruiting, 2 completed, 1 unknown. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Recruiting 3, Completed 2

Follow Hereditary Cancer Syndrome: new trials by email Literature Review of Hereditary Cancer Syndrome trials Research Report on Hereditary Cancer Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EHR Intervention to Increase HBOC Genetic Testing
ELISABETH Evidence-Informed Program (EIP) - Breast Cancer, Ovarian Cancer
Not applicableRecruitingColumbia University552026-09-012026-10-15
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
Natera empower comprehensive hereditary cancer panel, Obstetrical carrier screening - Hereditary Cancer Syndrome
RecruitingColumbia University10002026-02-122026-10-21
CfDNA in Hereditary And High-risk Malignancies 2
Cell-free DNA analysis - Hereditary Cancer Syndrome
RecruitingUniversity Health Network, Toronto10002024-04-192026-10-08
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
LYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System) - Lynch Syndrome, Lynch Syndrome I
RecruitingSan Raffaele University3002023-06-012026-04-24
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Sequential EHR Communications - Genetic Predisposition to Disease, Breast Cancer Female
Not applicableCompletedAbramson Cancer Center at Penn Medicine12832023-05-012026-06-17
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Chatbot - Gynecologic Cancer, Hereditary Cancer Syndrome
Not applicableRecruitingWeill Medical College of Cornell University1502023-01-152026-06-23
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
Mainstream Genetic Testing Model, Enhanced Standard of Care Model - Hereditary Cancer Syndrome
Not applicableRecruitingUniversity of Illinois at Chicago802022-08-012026-01-14
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Data and Specimen Collection - Li-Fraumeni Syndrome, TP53 Gene Mutation
RecruitingDana-Farber Cancer Institute15002020-09-152026-03-27
Evaluation of the Adhesion to the GENEPY Network
inclusion of subjects in the GENEPY network - Hereditary Cancer Syndrome, Hereditary Breast and Ovarian Cancer
UnknownInstitut Claudius Regaud4502019-08-012019-06-07
Integrative Sequencing In Germline and Hereditary Tumours
Hereditary Cancer Syndrome, High-Risk
Active not recruitingUniversity Health Network, Toronto102018-10-022025-12-03
Cancer Health Assessments Reaching Many
Modified genetic counseling, Traditional genetic counseling - Hereditary Cancer Syndrome
Not applicableCompletedKaiser Permanente9672018-08-152025-09-11
Cell-free DNA in Hereditary And High-Risk Malignancies 1
Next generation sequencing (NGS) - Hereditary Cancer Syndrome
Active not recruitingUniversity Health Network, Toronto14162018-07-012026-01-14

Narrower conditions

Neoplastic Syndromes, Hereditary (12)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (5)  ·  Hereditary Breast and Ovarian Cancer Syndrome (5)  ·  Breast Neoplasms (2)  ·  Li-Fraumeni Syndrome (2)  ·  Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Colorectal Neoplasms (1)  ·  Disease Susceptibility (1)  ·  Endometrial Neoplasms (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Predisposition to Disease (1)  ·  Lynch Syndrome II (1)  ·  Lynch syndrome I (site-specific colonic cancer) (1)  ·  Stomach Neoplasms (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Genetic Diseases, Inborn (11)  ·  Neoplasms (10)  ·  Female Urogenital Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Genital Diseases (7)  ·  Genital Diseases, Female (7)  ·  Genital Neoplasms, Female (7)  ·  Neoplasms by Site (7)  ·  Urogenital Diseases (7)  ·  Urogenital Neoplasms (7)  ·  Adnexal Diseases (6)  ·  Breast Diseases (6)  ·  DNA Repair-Deficiency Disorders (6)  ·  Endocrine Gland Neoplasms (6)

Interventions

High-Throughput Nucleotide Sequencing (1)  ·  Specimen Handling (1)

Sponsors

University Health Network, Toronto (3)  ·  Columbia University (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Dana-Farber Cancer Institute (1)  ·  Institut Claudius Regaud (1)  ·  Kaiser Permanente (1)  ·  San Raffaele University (1)  ·  University of Illinois at Chicago (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (8)  ·  Canada (3)  ·  France (1)  ·  Italy (1)

Top investigators

Raymond Kim, MD (3)  ·  Benjamin S Wilfond, MD (1)  ·  Giulia Martina Cavestro, MD, PhD (1)  ·  Judy E Garber, MD, MPH (1)  ·  Katherine Crew, MD (1)  ·  Melissa K Frey, MD (1)  ·  Michael Leo, PhD (1)  ·  Shayan Dioun, MD (1)

Results publications

PMID 15951961, PMID 16632260, PMID 33984519, PMID 35352025, PMID 35689290, PMID 37126135, PMID 37481477, PMID 37932730, PMID 39237276, PMID 42498079

NIH funding

R01CA242218 (1), U01HG007292 (1), UG3CA297490 (1)